Home » Products » Pharmaceutical Drugs » CYTOPLATIN 50MG - CISPLATIN

CYTOPLATIN 50MG - CISPLATIN

CYTOPLATIN 50MG - CISPLATIN
CYTOPLATIN 50MG - CISPLATIN
Send Inquiry
Product Code : 032
Price And Quantity
  • Minimum Order Quantity
  • 100000
  • Unit of Measure
  • Piece/Pieces,
  • Price
  • 250/Vial INR
Product Specifications
  • Drug Type
  • Injection
  • Physical Form
  • Liquid
  • Function
  • Anti-Cancer
  • Dosage
  • 50 mg
  • Suitable For
  • Adults
Product Description

CYTOPLATIN 50MG - CISPLATIN

Cytoplatin - Cisplatin, cisplatinum, or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas, and germ cell tumors. It was the first member of a class of anti-cancer drugs which now also includes carboplatin and oxaliplatin. These platinum complexes react in vivo, binding to and causing cross linking of DNA which ultimately triggers apoptosis (programmed cell death).

Indications: malignant neoplasms

Metastatic Testicular Tumors - In established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors who have already received appropriate surgical and/or radio therapeutic procedures. Metastatic Ovarian Tumors - In established combination therapy with other approved chemotherapeutic agents in patients with metastatic ovarian tumors who have already received appropriate surgical and/or radio therapeutic procedures. An established combination consists of Cytoplatin and cyclophosphamide. Cisplatin, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumors refractory to standard chemotherapy who have not previously received Cytoplatin therapy. Advanced Bladder Cancer - Cytoplatin is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments such as surgery and/or radiotherapy.

Trade Information
  • Payment Terms
  • Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 100000 Per Week
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

DHEER HEALTHCARE PRIVATE LIMITED
X


DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.